Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more. Founded by Anand Kesavaraju, Karthik Balakrishnan, and Vincent Tuminelli in 2014, Nodexus is backed by RA Capital Management, Section 32, Berkeley SkyDeck, Astia Angels, and Palapa Ventures and is headquartered in Berkeley.
FOUNDED:
2014
INDUSTRY:
Biopharma, Biotechnology, Health Care
FOUNDERS:
Anand Kesavaraju, Karthik Balakrishnan, Vincent Tuminelli
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
